Bafrekalant |
Catalog No.GC64861 |
Bafrekalant is a diazabicyclic substituted imidazo[l,2-a]pyrimidine-derivative.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2256770-44-0
Sample solution is provided at 25 µL, 10mM.
Bafrekalant is a diazabicyclic substituted imidazo[l,2-a]pyrimidine-derivative. Bafrekalant has the potential for the research of breathing disorders, including sleep-related breathing disorders such as obstructive and central sleep apnea and snoring (extracted from patent WO2018228907A1).
[1]. Martina Delbeck, et al. Diazabicyclic substituted imidazopyrimidines and their use for the treatment of breathing disorders. Patent WO2018228907A1.
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *